BIORESEARCH PHARMA SPÓŁKA AKCYJNA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
BIORESEARCH PHARMA SPÓŁKA AKCYJNA
Contacts
Registered address
Copy
Not calculatedReliability
Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.
Incorporation date
14/03/2024Share capital
274,777.20 PLNRepresentatives
3Representatives rights
W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO JEDYNY CZŁONEK ZARZĄDU UPRAWNIONY JEST DO SAMODZIELNEJ REPREZENTACJI SPÓŁKI. W PRZYPADKU ZARZĄDU WIELOOSOBOWEGO DO REPREZENTOWANIA SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
Łukasz Jarosław Zybaczyński | Chairman of the management board |
Robert Litka | Member of the management board |
Marian Popinigis | Supervisory authority member |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-4,770,657Net Profit (zł)
-4,770,657Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2023 |
|---|
| 2,000 |
| -1,007,910 |
| -1,007,910 |
| 551.43 |
| 3.46 |
| -50,395.50 |
| 1,155,523 |
| 448,569 |
| 0 |
| 70,772 |
| 2024 |
|---|
| 0 |
| -4,770,657 |
| -4,770,657 |
| - |
| 7.67 |
| - |
| 7,430,332 |
| 1,103,568 |
| 0 |
| 92,272 |
| 2024 |
|---|
| 0 |
| -4,770,657 |
| -4,770,657 |
| - |
| 7.67 |
| - |
| 7,430,332 |
| 1,103,568 |
| 0 |
| 92,272 |
Turnover (zł)
2024
Turnover (zł)
0 zł
-100 % *
Profit before tax (zł)
-4,770,657 zł-373 % *
Net Profit (zł)
-4,770,657 zł-373 % *
Working capital requirement (%)
-Liquidity ratio
7.67 
121.68 % *
Net profitability (%)
-Equity (zł)
7,430,332 zł543 % *
Current liabilities (zł)
1,103,568 zł146 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
92,272 zł
30 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Order report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
BIORESEARCH PHARMA SPÓŁKA AKCYJNA Documents
Date | Description |
|---|---|
01/07/2025 | OD 01.01.2024 DO 31.12.2024 |
27/06/2024 | OD 01.01.2023 DO 31.12.2023 |